TMO vs BMY
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Bristol-Myers Squibb Company, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | BMY |
|---|---|---|
| Price | $675.00 | $62.86 |
| Market cap | $249.58B | $128.41B |
| P/E ratio | 36.4 | 13.8 |
| ROE | 13.51% | 46.60% |
| Profit margin | 15.04% | 18.87% |
| Revenue growth | 10.50% | 5.70% |
| Dividend yield | 0.28% | 4.01% |
| Beta | 0.85 | 0.23 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs BMY in plain English
- TMO is the bigger company — about 1.9× the market cap of BMY.
- BMY is cheaper on earnings (P/E 13.8 vs 36.4).
- BMY earns a higher return on equity (47% vs 14%).
- TMO is growing revenue faster (10% vs 6%).
- BMY has the higher dividend yield (4.01% vs 0.28%).
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
BMY return calculator
See what $1,000 in Bristol-Myers Squibb Company would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.